Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole plus dexamethasone vs letrozole alone for ovulation induction in infertile women with polycystic ovary syndrome
IRCT20230522058253N8Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in polycystic ovary syndrome (PCOS) and female infertility comparing Letrozole plus dexamethasone with Letrozole alone (2 arms). Primary endpoint: Ovulation rate. Started Nov 2025; status: completed.
02
Drugs
letrozoledexamethasone
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on IRCT20230522058253N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230522058253N8.